— The Josh Carrick Foundation

Please see below for the Save the date for The JCF Fundraising Dinner. Contact us to reserve a table as they sell out fast!

JCF Dinner 2019

Read More

On the 6th July 2019 Alison Green opened her gardens to the public to raise money for the Josh Carrick Foundation.

On a perfect sunny July afternoon an 8-piece jazz band, ‘Stolen Moments’, and Flamenco group ‘Escuela de Baile de Londres’ entertained over 220 visitors. Guests listen to Jazz as the birds sang and the sun shined and explored the amazing two-acre piece of tranquil space in London, created by award-winning gardener Alison Green. The Flamenco group added some more colour and fun to a great afternoon.

The tearoom was manned by a host of volunteers, friends and family of the foundation and Alison, offering afternoon tea and cake, wine, beer, and bubbly! A huge raffle saw people walking home with sunflowers, candles, jams and much more, raising over £1,000.

The event raised over £4,000 for the Josh Carrick foundation, a lovely afternoon for a great cause.

Thank you to all who came along and supported and to Alison Green for her continued support of the foundation.


Read More

Big love to all our London to Brighton Bike riders. Here are a few snaps from the day!

20180916_113515_resized_1 20180916_115715_resized_1 20180916_120340_resized_1 20180916_120910_resized_1 20180916_120910_resized_2 20180916_121135_resized_1 20180916_121135_resized_2 20180916_124842_resized_1 20180916_124842_resized_2 20180916_124912_resized_1 20180916_124912_resized_2 20180916_125306_resized_1 20180916_125743_resized_1 20180916_130428_resized_1 20180916_131351_resized_1 20180916_141607_resized 20180916_145854_resized 20180916_154259_resized 20180916_170058_resized

Read More

Massive thank you to our supporters who have helped us fund some fantastic research at the Francis Crick Institute. To read more please click the link below.

Francis Crick Institute’s 2017/18 Annual Review

Francis Crick Institute's 2017/18 Annual Review

Read More

“Exponential-e chose the Josh Carrick Foundation as it truly is for a great cause and opened so many eyes to testicular cancer, especially the 80 young lads playing with us at the event, this event was a great success and even better Steve could be here to accept the cheque. We hope to continue raising for them in future and bring on the next channel cup in 2019”

Ruby Wade, Channel Marketing Executive, Exponential-e Limited

Thanks to all who took part an amazing 7k raised for the Josh Carrick Foundation! #takesballs 

Read More

The Josh Carrick Foundation was honoured for a sixth time as charity of choice for the Resi Awards.

Donation envelopes were left on each table for guests with a prize draw to win a visit to the Francis Crick Institute (a world leading interdisciplinary medical research facility and the largest of its kind in Europe).  We raised over £12,000 so thank you to everyone for their generous donations.

We were delighted to be able to provide an update about the Foundation and Trustee Laura Nyavie gave a fantastic speech – some pics of this below.

A huge thank you from all the trustees to everyone at the RESI Awards and Property Week for their help organising this opportunity for us.

Read More

The Francis Crick Institute is a world leading interdisciplinary medical research facility and the largest of its kind in Europe. The institute hosts world leading researchers, dedicated to tackling the biggest questions that face health research today. At the heart of the institute is a drive to promote cross-fertilisation between studies of different diseases. The revolutionary method hopes to promote sharing of research across disciplines, heightening the impact of key findings to reach a range of diseases. Cancer research is key within this, and the Josh Carrick Foundation are proud to be long supporters of Dr Erik Sahai, who recently moved to the Crick.

At the Josh Carrick Foundation charity fundraising dinner last November we were lucky to offer an auction prize of an exclusive tour of this incredible institute. Here are a few pics from the day of our JCF supporters Steve and Sue Lestrange on the tour.


Want to know more? Read the Crick One Year On update here

Read More


To complete a Spartan Trifecta takes physical and mental strength, pushing you to your absolute limit every step of the way.

Angelo will have to finish one of every Spartan distance – Sprint, Super and Beast (or Ultra) – in a calendar year (January 1st – December 31st), anywhere in the world.

Sprint: 5km+, 20+ obstacles

Super: 13km+, 25+ obstacles

Beast: 20km+, 30+ obstacles

To show your support you can sponsor Angelo here: https://www.justgiving.com/fundraising/nact

Good luck Angelo from all of us at JCF! Big love xxx

Read More

An interview with Dr Pule about his lab’s pioneering immunotherapy work at UCL Cancer Institute that the Josh Carrick Foundation is helping to fund.

Read More

Update from The Royal Marsden Cancer Charity

Dr Robert Huddart

Your generous gifts support the life-changing testicular cancer research driven by world-leading experts at The Royal Marsden. We are very grateful to The Josh Carrick Foundation, and to everyone who fundraises for and donates to the Foundation throughout the year. Thanks to you, we are able to continue innovating kinder, more effective treatments for this disease.
It is with great pleasure that we provide an update on the progress Professor Robert Huddart has been able to make with the Platinum Study over the past few months.

The Platinum Study

In the UK, the number of people diagnosed with testicular cancer is projected to rise by 12% over the next 20 years. The prognosis for patients is continuing to improve, largely thanks to the continued development of effective treatments like the chemotherapy drug, cisplatin. Therefore, it is more important than ever that we ensure all patients can enjoy the best quality of life in their survivorship years.

Through The Platinum Study, Professor Huddart and his team aim to examine the long-term health of men who have been treated for testicular cancer with cisplatin chemotherapy. Specifically, the study is exploring ototoxicity (damage to the ear, affecting hearing and balance) and neurotoxicity (damage to the nervous system, causing numbness or affecting the brain) resulting from cisplatin.
As part of their participation in the study, patients provide a blood sample, complete a questionnaire on their quality of life, allow vital signs to be collected, and attend a hearing test. The research team will then analyse each patients’ genetic makeup and the side effects they are experiencing from treatment. They hope to be able to identify the genes that are associated with severe side effects, in order to help doctors determine which patients should receive cisplatin, and which would benefit from an alternative treatment.

Our progress so far

A large number of the patient population who attend our testicular cancer clinic are eligible for the study and we have been able to consistently recruit four to five patients each week. Patients are keen to participate and share their experiences of the treatment and the side effects they have experienced. Since the study opened in March 2016, we have now recruited nearly 150 participants. Despite starting recruitment two years after our partners in the United States, we are proud to be one of the highest recruiters in the study.

Early results have documented high levels of cisplatin-induced hearing problems in patients with a particular gene. Excitingly, this means that in the future, doctors could use this information to avoid prescribing cisplatin to people who carry this gene, thus saving them from suffering hearing problems later in life.

Our next steps

In order to reach our target recruitment, we have recently received approval to extend the study to July 2018. Furthermore, Professor Huddart is currently speaking with the lead institution in the United States, to discuss potentially extending the study for an additional five years. This will enable the international research teams to gather a vast evidence base, develop their work further, and, ultimately, have a more significant impact on how treatment decisions are made for individual patients.

Thank you

As a specialist cancer hospital with an international reputation, we have a responsibility to innovate and ensure that we continue to drive forward advances in treatment to give the ever-growing number of cancer patients a greater chance of being cured.

We are making incredible progress and changing countless lives, but none of this is possible without donations from those who are passionate about making a difference and investing in a better future. Thank you for your committed support. Together, we can develop better, kinder treatments for patients at The Royal Marsden and world-wide.

Read More